lomitapide sold brand name juxtapid us lojuxta eu medication used lipidlowering agent treatment familial hypercholesterolemia developed aegerion tested clinical trials single treatment combinations atorvastatin ezetimibe us food drug administration fda approved lomitapide december orphan drug reduce ldl cholesterol total cholesterol apolipoprotein b nonhighdensity lipoprotein nonhdl cholesterol people homozygous familial hypercholesterolemia july european commission approved lomitapide adjunct lowfat diet lipidlowering medicinal products without low density lipoprotein ldl apheresis adults lomitapide inhibits microsomal triglyceride transfer protein mtp mttp necessary lowdensity lipoprotein vldl assembly secretion december drug manufacturer aegerion announced approved fda adjunct lowfat diet lipidlowering treatmentsin patients homozygous familial hypercholesterolemia phase iii study lomitapide led elevated aminotransferase levels fat accumulation httpsenwikipediaorgwikilomitapide